MiraeING.Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 11, 2022 at 02:19 am EST
Share
MiraeING.Co.,Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 2,524.23 million compared to KRW 1,619.59 million a year ago. Net loss was KRW 2,260.93 million compared to KRW 366.96 million a year ago. Basic loss per share from continuing operations was KRW 85 compared to KRW 15 a year ago. Diluted loss per share from continuing operations was KRW 85 compared to KRW 15 a year ago.
For the nine months, sales was KRW 7,067.58 million compared to KRW 5,866.88 million a year ago. Net loss was KRW 7,996.43 million compared to net income of KRW 1,852.26 million a year ago. Basic loss per share from continuing operations was KRW 305 compared to basic earnings per share from continuing operations of KRW 30 a year ago. Diluted loss per share from continuing operations was KRW 305 compared to diluted earnings per share from continuing operations of KRW 30 a year ago.
MiraeING.Co.,Ltd., formerly Theall Medi Bio. Co.,Ltd., is a Korea-based company mainly engaged in solution business and video business. The Company operates in three main segments: solution segment, which provides project consulting, construction and maintenance services and related products for banks under the brand name XiT, eNisis and others; video segment, which provides digital video recorders (DVRs) and closed circuit television (CCTV) systems for security areas, and defense segment, which provides self-propelled artilleries and components. It also engages in the leasing of non-residential buildings.
MIRAEING.CO.,LTD. 
